Literature DB >> 22460204

Hereditary thrombophilic risk factors for recurrent pregnancy loss.

Nadja Bogdanova1, Arseni Markoff.   

Abstract

This review summarizes current knowledge about the role of hereditary hypercoagulation factors predisposing to thrombophilia-associated recurrent fetal loss. Thrombophilias are a major cause of adverse pregnancy outcome, playing a role in the etiology of up to 40% of cases worldwide. Hereditary thrombophilic predispositions to recurrent pregnancy wastage include genetic lesions in blood coagulation factors II and V as well as natural anticoagulants antithrombin, protein C, and protein S. Furthermore, methylenetetrahydrofolate reductase gene variants conferring higher thrombophilia risk in combination with these mutations and the newly described annexin A5 gene M2 promoter allele are associated with repeated fetal loss. The review gives a concise description of the molecular defects arising from the genetic changes, of the role these factors play in the timing and definition of fetal loss, and risk estimates from available studies and meta-analysis. This knowledge is instrumental for a more precise assessment of individual risks for repeated fetal loss and should guide therapeutic strategies, where relevant. Since the average childbearing age increases in Western societies, the importance of a timely diagnosis of fetal loss predisposition is increasing.

Entities:  

Year:  2010        PMID: 22460204      PMCID: PMC3185986          DOI: 10.1007/s12687-010-0011-3

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  63 in total

1.  A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy.

Authors:  E F van der Molen; G E Arends; W L Nelen; N J van der Put; S G Heil; T K Eskes; H J Blom
Journal:  Am J Obstet Gynecol       Date:  2000-05       Impact factor: 8.661

2.  Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia.

Authors:  N H Gehring; U Frede; G Neu-Yilik; P Hundsdoerfer; B Vetter; M W Hentze; A E Kulozik
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

3.  C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.

Authors:  N Q Hanson; O Aras ; F Yang; M Y Tsai
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

4.  Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?

Authors:  Cyle S Goodman; Carolyn B Coulam; Rajasingam S Jeyendran; Vida A Acosta; Roumen Roussev
Journal:  Am J Reprod Immunol       Date:  2006-10       Impact factor: 3.886

5.  Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Authors:  J Voorberg; J Roelse; R Koopman; H Büller; F Berends; J W ten Cate; K Mertens; J A van Mourik
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

Review 6.  Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.

Authors:  Marianne Empson; Marissa Lassere; Jonathan C Craig; James R Scott
Journal:  Obstet Gynecol       Date:  2002-01       Impact factor: 7.661

7.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Shannon M Bates; Ian A Greer; Ingrid Pabinger; Shoshanna Sofaer; Jack Hirsh
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 8.  Hyperhomocysteinemia and thrombosis: an overview.

Authors:  Mohamed M Eldibany; Joseph A Caprini
Journal:  Arch Pathol Lab Med       Date:  2007-06       Impact factor: 5.534

9.  Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2.

Authors:  Elena Chinni; Giovanni Luca Tiscia; Donatella Colaizzo; Patrizia Vergura; Maurizio Margaglione; Elvira Grandone
Journal:  Fertil Steril       Date:  2008-05-07       Impact factor: 7.329

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  5 in total

1.  Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.

Authors:  Amit Sharma; Teena Bhakuni; Ravi Ranjan; Ravi Kumar; Kamal Kishor; Vineet Kumar Kamal; Manoranjan Mahapatra; Mohamad Aman Jairajpuri; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

2.  Polymorphisms of methalenetetrahydrofolate reductase in recurrent pregnancy loss: an overview of systematic reviews and meta-analyses.

Authors:  Boran Du; Xiangjun Shi; Chenghong Yin; Xin Feng
Journal:  J Assist Reprod Genet       Date:  2019-06-28       Impact factor: 3.412

3.  Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications.

Authors:  Nina Rogenhofer; Lara R M Nienaber; Lea C Amshoff; Nadia Bogdanova; David Petroff; Peter Wieacker; Christian J Thaler; Arseni Markoff
Journal:  J Assist Reprod Genet       Date:  2017-09-13       Impact factor: 3.412

4.  Genetic analysis of the M2/ANXA5 haplotype as recurrent pregnancy loss predisposition in the Malay population.

Authors:  Kai-Cheen Ang; Sushilnathan Kathirgamanathan; Ewe Seng Ch'ng; Yan-Yeow Lee; Anna-Liza Roslani; Bavanandan Naidu; Krishna Kumar; Ridzuan Abdullah; Siti-Nadiah Abdul Kadir; Narazah Mohd Yusoff; Wan Zaidah Abdullah; Nadja Bogdanova; Peter Wieacker; Arseni Markoff; Thean-Hock Tang
Journal:  J Assist Reprod Genet       Date:  2017-01-20       Impact factor: 3.412

5.  Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (Gypsy) populations.

Authors:  Alexandra Bozikova; Dana Gabrikova; Jozef Pitonak; Jarmila Bernasovska; Sona Macekova; Regina Lohajova-Behulova
Journal:  Genet Test Mol Biomarkers       Date:  2014-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.